Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05030259

The Research About the ACS After Femoropopliteal Arterial Injuries

Crural Compartment syndrome is a well-known sequela after femoropopliteal arterial injuries in the lower extremity, particularly when there has been a long period of ischemia,need for ligation of a major vein, or when there is severe associated soft tissue.There is conteoversy in the treatment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

the Third Hospital of Hebei Medical Univesity

Shijiazhuang, Hebei, 050000, China

Location status: Recruiting

Location contact

Sun Changsheng

CONTACT

[email protected]

15176139310

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with femoropopliteal arterial injuries
  • patients older than 18 years

Exclusion criteria

  • Patients who did not survive to discharge
  • Patients with primary amputation
  • patients younger than 18 years

Treatment and study plan

fasciotomy

Procedure

To perform fasciotomy

Primary outcomes

  1. the rate of amputation

    Time frame: up to 6 months

  2. fasciotomy performed or not

    Time frame: up to 2 weeks

Secondary outcomes

  1. the rate of primary skin closure

    Time frame: up to 1 months

  2. hospital lengths of stay

    Time frame: up to 6 months

  3. injury mechanism of patients

    Time frame: up to 1 week

  4. the costs of hospitalization

    Time frame: up to 2 months

  5. tourniquet used or not

    Time frame: up to 1 week

  6. the time of using tourniquet

    Time frame: up to 1 week

  7. the time to surgical intervention

    Time frame: up to 1 month

  8. extremity Abbreviated Injury Scale of patients

    Time frame: up to 1 week

    minimum is 1, maximum is 6, higher scores mean a worse outcome

  9. Injury Severity Score of patients

    Time frame: up to 1 week

    minimum is 0, maximum is 75, higher scores mean a worse outcome

  10. concomitant injury of patients

    Time frame: up to 1 week

  11. time of skin closure

    Time frame: up to 1 month

  12. admission hemoglobin of patients

    Time frame: up to 1 month

  13. admission pH of patients

    Time frame: up to 1 month

  14. admission lactate of patients

    Time frame: up to 1 month

  15. postoperative lactate of patients

    Time frame: up to 1 month

  16. admission International Normalized Ratio of patients

    Time frame: up to 1 month

  17. postoperative International Normalized Ratio of patients

    Time frame: up to 1 month

  18. admission CK of patients

    Time frame: up to 1 month

  19. postoperative CK of patients

    Time frame: up to 1 month

  20. admission LDH of patients

    Time frame: up to 1 month

  21. postoperative LDH of patients

    Time frame: up to 1 month

  22. Number of Participants with Lower Extremity Arteriosclerosis Obliterans

    Time frame: up to 1 week

  23. vascular repair technique of patients

    Time frame: up to 1 week

  24. Number of Participants with sepsis

    Time frame: up to 1 month

  25. Ischemia time of patients

    Time frame: up to 1 week

  26. Postoperative knee function of patients

    Time frame: up to 6 month

Study contacts

Contact information is provided by the study sponsor or research team.

Guo Jialiang, Doctor

CONTACT

[email protected]

18203222090

Sponsors and collaborators

Lead sponsor

Hebei Medical University Third Hospital

Other

Registry information

Official study title

ACS After Femoropopliteal Arterial Injuries

Important dates

Study start
2021
Primary completion
2023
Study completion
2030
First posted
Sep 1, 2021
Registry last updated
Sep 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.